AI assistant
BOSTON SCIENTIFIC CORP — Director's Dealing 2019
Mar 12, 2019
29821_dirs_2019-03-12_eae63721-5185-4d46-a6c4-ffbd5e86b098.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2019-03-11
Reporting Person: Carruthers Wendy (SVP, Human Resources)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-03-11 | Common Stock | M | 29412.0000 | $7.4700 | Acquired | 200751.0000 | Direct |
| 2019-03-11 | Common Stock | S | 29412.0000 | $39.6327 | Disposed | 171339.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-03-11 | Stock Option (Right to Buy) | $7.4700 | M | 29412.0000 | Disposed | 2021-03-07 | Common Stock (29412.0000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $39.52 to $39.73, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in whole on March 7, 2015, the fourth anniversary of the grant.